DePuy Synthes Unveils VELYS ™ Robotic-Assisted Solution In Australia: The Next Generation Robotic-Assisted Solution For Knee Replacement Surgery Designed For Use With The ATTUNE® Knee System

Sydney, Australia, July 20, 2021 -- DePuy Synthes, the orthopaedics company of Johnson & Johnson, today announced that Australian orthopaedic surgeons will be among the first in the world to access the next generation of robotics. The VELYS™ Robotic-Assisted Solution, indicated for use with the ATTUNE® Knee System for total knee arthroplasty, has recently been included on the Australian Register of Therapeutic Goods (ARTG).Sue Martin, Managing Director of Johnson & Johnson Medical Australia and New Zealand says: “Australia joins an exclusive list of just a few countries with access to this technology to date. The introduction of the VELYS Robotic-Assisted Solution is testament to Johnson & Johnson Medical Device’s ongoing commitment to create innovative technologies that help hospitals and surgeons improve patient outcomes and advance the sustainability of Australia’s healthcare system.”An increasing number of surgical procedures utilise robotic assistance[iii]. However, the impact of robotic technology on operational efficiency, including surgical time and the technological learning curve, has been reported as a drawback.[iv] The VELYS Robotic-Assisted Solution is designed to respond to this challenge as a first-of-its-kind operating table mounted solution that adapts to the surgeon’s workflow and utilises advanced planning capabilities, proprietary technology, and a next generation design to help surgeons accurately resect bones that align and posit...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news